Fundraising Fox
Agile Therapeutics
Princeton, US · Delaware corporation · 8 employees on LinkedIn · 3 known investors
Find your way into Agile Therapeutics
Sign up to see every warm intro you have to Agile Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Agile Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusion® transdermal technology platform. The company focuses on providing healthcare options for women through innovative delivery mechanisms.
Founders & leadership
KM
Katie MacFarlaneChief Commercial Officer2009–2016Katie MacFarlane is Executive Officer at Agile Therapeutics, which develops contraceptive and women's health products using transdermal technology. She has spent over 35 years in pharmaceutical roles including senior management positions at Hoffmann-LaRoche, Parke-Davis, Pfizer, and Warner Chilcott, with experience in marketing, sales, clinical research, and product launch strategy.
SM
Scott M. CoianteExecutive
AA
Al AltomariChairman & CEO2010–2024Al Altomari served as Chairman and CEO of Agile Therapeutics from 2010 until its merger with InSud Pharma, and previously led Barrier Therapeutics as CEO before its 2008 acquisition by GSK/Stiefel Laboratories. He spent over two decades at Johnson & Johnson in roles spanning finance, business development, and general management, including serving as General Manager of Ortho Neutrogena and heading the Women's Health Care Franchise.
EG
Elizabeth GarnerChief Medical Officer2014–2019Elizabeth Garner has over a decade of experience in women's health, including work in clinical development, regulatory strategy, and assessment of therapeutics and devices. She serves as Board Chair at NUA Surgical and Owner and President of KNI Health Consultants, LLC.
Board
KH
AL
Abhijeet LeleBoard director
AN
LP
Lorenzo PellegriniBoard director
WT
William T. McKeeBoard director
JH
John HubbardBoard director
JT
James TursiBoard director
Investors · 3
Aisling Capitallisted by Aisling CapitalNew York
How we know: Aisling Capital's portfolio page · a partner's Signal profile · Not right? Tell us
Kaiser Permanente Ventureslisted by Kaiser Permanente VenturesSan Francisco · $2M – $5M
How we know: Kaiser Permanente Ventures's portfolio page · Not right? Tell us
De Novo VenturesreportedBoston
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$30.8M disclosed across 3 rounds · 2014–2019
▶$7.8MraisedMar 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$7.8MraisedMar 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Seth H.Z. FischerDirector
- William T. McKeeDirector
- James P. TursiDirector
- Abhijeet LeleDirector
- Scott M. CoianteExecutive Officer
- Al AltomariExecutive Officer, Director
- Elizabeth GarnerExecutive Officer
- Ajit S. ShettyDirector
- John HubbardDirector
- Robert G. ConwayExecutive Officer
- Geoffrey P. GilmoreExecutive Officer
- Offering amount
- $7.8M
- Amount sold
- $7.8M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedFeb 2015 · 8 investors · PharmaceuticalsRule 506(b)
▶$20MraisedFeb 2015 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Katie MacFarlaneExecutive Officer
- Karen HongDirector
- William T. McKeeDirector
- John HubbardDirector
- Scott M. CoianteExecutive Officer
- Al AltomariExecutive Officer, Director
- Abhijeet LeleDirector
- Elizabeth GarnerExecutive Officer
- Andrew N. SchiffDirector
- James TursiDirector
- Offering amount
- $20M
- Amount sold
- $20M
- Sales commissions
- $600K
- Placement agents
- William Blair & Company, L.L.C.
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedMay 2014 · 9 investors · PharmaceuticalsRule 506(b)
▶$3MraisedMay 2014 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Katie MacFarlaneExecutive Officer
- Elizabeth GarnerExecutive Officer
- Karen HongDirector
- Al AltomariExecutive Officer, Director
- Scott M. CoianteExecutive Officer
- Andrew N. SchiffDirector
- Abhijeet LeleDirector
- William T. McKeeDirector
- Lorenzo PellegriniDirector
- Offering amount
- $3M
- Amount sold
- $3M
- Proceeds to insiders
- $300K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Pandia HealthPandia Health is a doctor-founded, women-led telehealth service that provides online consultations with board-certified physicians specializing in hormonal and reproductive care, along with free home delivery of prescriptions. It offers personalized hormone therapy for needs such as birth control, hormonal balance, menopause, and sexual wellness, using medication-matching technology and patient data.
PlushCarePlushCare is a telehealth service that connects patients with board-certified primary care doctors and therapists through an app for virtual appointments, prescriptions, and ongoing care. It covers weight management, urgent care, pediatric care, chronic disease treatment, online therapy, and prescription discounts, serving patients across all 50 U.S. states.
WalgreensWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies working in the same space as Agile Therapeutics.
Frequently asked questions
- What does Agile Therapeutics do?
- Agile Therapeutics develops and markets contraceptive and women's health products using its proprietary Skinfusion® transdermal technology platform. The company focuses on providing healthcare options for women through innovative delivery mechanisms.
- Who are Agile Therapeutics's investors?
- Agile Therapeutics's investors include Aisling Capital, Kaiser Permanente Ventures, De Novo Ventures.
- How much funding has Agile Therapeutics raised?
- Agile Therapeutics has disclosed $30.8M raised across 3 rounds.
- Where is Agile Therapeutics headquartered?
- Agile Therapeutics is headquartered in Princeton, US.